323 related articles for article (PubMed ID: 6947407)
1. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
2. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
3. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
Michalsen H; Bergan T
Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
[TBL] [Abstract][Full Text] [Related]
4. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Grenier B; Gilly R
Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
[TBL] [Abstract][Full Text] [Related]
5. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Michalsen H; Bergan T
Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
9. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Lau WK; Young LS; Osher AB; Dooley RR
Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
[TBL] [Abstract][Full Text] [Related]
10. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy. (Comparison between the intramuscular route, the endotracheal instillation and aerosolization).
Baran D; Dachy A; Klastersky J
Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):336-41. PubMed ID: 809371
[TBL] [Abstract][Full Text] [Related]
11. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
12. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A; Hodson ME; Gaya H; Batten JC
Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
[TBL] [Abstract][Full Text] [Related]
13. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
[TBL] [Abstract][Full Text] [Related]
15. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].
Rosselli P; Marianelli L; Valenza T; Bartolozzi G
Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104
[TBL] [Abstract][Full Text] [Related]
16. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
17. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
[TBL] [Abstract][Full Text] [Related]
18. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa.
Gonzalez MA
J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600
[TBL] [Abstract][Full Text] [Related]
19. Carbenicillin in pulmonary infection complicating cystic fibrosis.
Africa E; Rosenblum H
Del Med J; 1970 Nov; 42(11):307-8. PubMed ID: 5481955
[No Abstract] [Full Text] [Related]
20. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
